Novel therapeutic targets in myeloma bone disease
Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists
Therapeutic targeting of the mTOR-signalling pathway in cancer: benefits and limitations
Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants
Effect of a toggle switch mutation in TM6 of the human adenosine A3 receptor on Gi protein-dependent signalling and Gi-independent receptor internalization
The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies
The α1B-adrenoceptor subtype mediates adrenergic vasoconstriction in mouse retinal arterioles with damaged endothelium
Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors
The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo
NPY/Y1 receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension
Activation of GPR18 by cannabinoid compounds: a tale of biased agonism
Electromechanical and atrial and ventricular antiarrhythmic actions of CIJ-3-2F, a novel benzyl-furoquinoline vasodilator in rat heart
Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease
Modulation of transglutaminase 2 activity in H9c2 cells by PKC and PKA signalling: a role for transglutaminase 2 in cytoprotection